Report an error

Spotted something inaccurate in “PPAR Agonists Elafibranor and Seladelpar Reframe PBC Treatment Beyond First-Line Therapy”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.